(2010). Cost-effectiveness analysis of anastrozole versus tamoxifen in adjuvant therapy for early-stage breast cancer: A health-economic analysis based on the 100-month analysis of the ATAC trial and the German health system.
Chicago-Zitierstil (17. Ausg.)Cost-effectiveness Analysis of Anastrozole Versus Tamoxifen in Adjuvant Therapy for Early-stage Breast Cancer: A Health-economic Analysis Based on the 100-month Analysis of the ATAC Trial and the German Health System. 2010.
MLA-Zitierstil (9. Ausg.)Cost-effectiveness Analysis of Anastrozole Versus Tamoxifen in Adjuvant Therapy for Early-stage Breast Cancer: A Health-economic Analysis Based on the 100-month Analysis of the ATAC Trial and the German Health System. 2010.
Achtung: Diese Zitate sind unter Umständen nicht zu 100% korrekt.